Matches in Wikidata for { <http://www.wikidata.org/entity/Q90759871> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q90759871 description "article scientifique publié en 2020" @default.
- Q90759871 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q90759871 description "scientific article published on 30 March 2020" @default.
- Q90759871 description "wetenschappelijk artikel" @default.
- Q90759871 description "наукова стаття, опублікована 30 березня 2020" @default.
- Q90759871 name "Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial" @default.
- Q90759871 name "Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial" @default.
- Q90759871 type Item @default.
- Q90759871 label "Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial" @default.
- Q90759871 label "Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial" @default.
- Q90759871 prefLabel "Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial" @default.
- Q90759871 prefLabel "Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial" @default.
- Q90759871 P1433 Q90759871-C522ACD9-69A5-41BA-8719-4D9C1EC11358 @default.
- Q90759871 P1476 Q90759871-4A1F5AE6-9246-45E5-90A0-2CBB650D5CB8 @default.
- Q90759871 P2093 Q90759871-06CEFB82-5D98-4921-89D3-4B47037FD96E @default.
- Q90759871 P2093 Q90759871-128F422B-48B4-4DD3-B65E-B42497E6C7B5 @default.
- Q90759871 P2093 Q90759871-22143E20-5FF4-4B61-B66A-4B96650263D4 @default.
- Q90759871 P2093 Q90759871-307B3E4D-621B-4896-9957-8C76CED3C2DB @default.
- Q90759871 P2093 Q90759871-3F4D3567-26A9-45E7-B8FF-8ED1C8CAF8BB @default.
- Q90759871 P2093 Q90759871-5184E210-8D5F-4D76-8FBA-4AA4DB7DE07D @default.
- Q90759871 P2093 Q90759871-5850D172-74E5-4F17-9A4B-B63BE20D3ACE @default.
- Q90759871 P2093 Q90759871-79ADBB3C-7944-4736-A69A-31AAF593688B @default.
- Q90759871 P2093 Q90759871-9346D39D-1DF9-4F4B-8248-75F7C5DC2629 @default.
- Q90759871 P2093 Q90759871-A89D6B39-0A64-43EC-948B-D6A334C66C99 @default.
- Q90759871 P2093 Q90759871-DECF3E0E-DEE5-4E6C-B266-F60E38542291 @default.
- Q90759871 P2093 Q90759871-FF38DF92-0E4C-482F-BB7A-6AD11DF683B6 @default.
- Q90759871 P304 Q90759871-D1CA032B-CC36-48A8-88F1-DBDC109E2F3D @default.
- Q90759871 P31 Q90759871-143026C0-26E9-4172-A205-DD171D4BB3B0 @default.
- Q90759871 P356 Q90759871-4C8E96E0-40C6-4916-B299-BE1AE479FB4D @default.
- Q90759871 P433 Q90759871-5D1DCE86-EC7B-4AE8-B5F7-7AF641234E48 @default.
- Q90759871 P478 Q90759871-7A43C942-3A37-479F-AD9B-BBEC19743BDC @default.
- Q90759871 P50 Q90759871-3BD4946E-3F89-4C5D-802E-DFC940F1F0A5 @default.
- Q90759871 P577 Q90759871-DF178B86-67F4-43CF-8DEA-D6D039C71242 @default.
- Q90759871 P698 Q90759871-E1A8FC51-BCF7-4DAF-AAEC-A767D8ABFB8E @default.
- Q90759871 P921 Q90759871-983EDDD1-5996-4E4B-BECD-BF41084D0D62 @default.
- Q90759871 P921 Q90759871-B4F8FF71-3A71-4B07-8265-6AB86617149D @default.
- Q90759871 P932 Q90759871-233307DA-6D83-4CCD-A81B-E601D92E49C2 @default.
- Q90759871 P356 S12885-020-06751-2 @default.
- Q90759871 P698 32228535 @default.
- Q90759871 P1433 Q326300 @default.
- Q90759871 P1476 "Phase II, multi-center, open-label, single-arm clinical trial evaluating the efficacy and safety of Mycophenolate Mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): rationale and design of the ESMMO trial" @default.
- Q90759871 P2093 "Chaiyut Charoentum" @default.
- Q90759871 P2093 "Dumnoensun Pruksakorn" @default.
- Q90759871 P2093 "Jeerawan Klangjorhor" @default.
- Q90759871 P2093 "Lalita Sathitsamitphong" @default.
- Q90759871 P2093 "Natavudh Townamchai" @default.
- Q90759871 P2093 "Nuttapong Ngamphaiboon" @default.
- Q90759871 P2093 "Parunya Chaiyawat" @default.
- Q90759871 P2093 "Pimlak Charoenkwan" @default.
- Q90759871 P2093 "Pimpisa Teeyakasem" @default.
- Q90759871 P2093 "Rungrote Natesirinilkul" @default.
- Q90759871 P2093 "Suradej Hongeng" @default.
- Q90759871 P2093 "Touch Ativitavas" @default.
- Q90759871 P304 "268" @default.
- Q90759871 P31 Q13442814 @default.
- Q90759871 P356 "10.1186/S12885-020-06751-2" @default.
- Q90759871 P433 "1" @default.
- Q90759871 P478 "20" @default.
- Q90759871 P50 Q56516208 @default.
- Q90759871 P577 "2020-03-30T00:00:00Z" @default.
- Q90759871 P698 "32228535" @default.
- Q90759871 P921 Q18975446 @default.
- Q90759871 P921 Q42824440 @default.
- Q90759871 P932 "7106788" @default.